Seres Therapeutics, Inc. - Cash Flow | Stock Club

MCRBSeres Therapeutics, Inc.$ --

Seres Therapeutics, Inc.

Name: Seres Therapeutics, Inc.（MCRB） Cash Flow Statement
Creator: Stock Club
License: https://stock-club.net/en/rule

MCRB

$ -

Review operating, investing, and financing cash flow trends alongside detailed breakdowns.

paymentsCash Flow (CF) Summary

Updated: 2026/06/30FY2026 Q2

Operating CF

-22.4M USD

YoY -68.5%

Investing CF

14,000USD

YoY +107.7%

Financing CF

1.7M USD

YoY -

Cash Flow Trend (5 Years)

Cash in goes right, cash out goes left.

Investing CF

Operating CF

Financing CF

2023–2025

2023Free CF -125.3M

Operating

Investing

Financing

-117.4M

+10.6M

+71.7M

2024Free CF -149M

Operating

Investing

Financing

-148.6M

+142.3M

-90.4M

2025Free CF +865,000

Operating

Investing

Financing

+1.1M

-42,000

+13.9M

64.1M

6.7M

1.2M

2021

82.4M

129.6M

-228.8M

2022

10.6M

71.7M

-117.4M

2023

142.3M

-148.6M

-90.4M

2024

1.1M

13.9M

-42,000

2025

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

6.7M64.1M-228.8M82.4M-117.4M10.6M-148.6M142.3M1.1M-42,0000

20212022202320242025

waterfall_chartCash Flow Bridge (FY2025 Full Year)

Beginning / Ending

Increase

Decrease

60M40M20M0-20M

39.5M

OpenBeginning Cash

1.1M

Op.Operating CF

-42,000

Inv.Investing CF

13.9M

Fin.Financing CF

OtherOther

54.4M

CloseEnding Cash

Cash Flow Details

Unit: USD

Net Income from Continuing Operations

5.70M

Depreciation and Amortization

4.13M

Depreciation and Amortization

4.13M

Stock-based Compensation

10.84M

Other Non-cash Items

8.23M

Adjustments to Net Income

8.23M

Other Operating Activity

8.23M

Change in Working Capital

-27.78M

Change in Account Receivables

1.55M

Change in Trade Receivables

1.55M

Change in Inventory

Change in Payables and Accrued Expenses

-2.40M

Other Working Capital Changes

-26.93M

Cash Flow from Operating Activities

1.12M

Net Fixed Asset Activity

-252,000

Net Investment Securities Activity

Other Investing Activity

Cash Flow from Investing Activities

-42,000

Net Borrowings

Net Issuance / Repurchase of Stock

13.90M

Issuance of Capital Stock

13.90M

Total Dividends Paid

Net Dividends Paid

Treasury / Other Financing Activity

Cash Flow from Financing Activities

13.90M

Beginning Cash and Cash Equivalents

39.46M

Net Change in Cash and Cash Equivalents

14.97M

Net Change in Cash and Cash Equivalents

14.97M

Exchange Rate Changes

Ending Cash and Cash Equivalents

54.43M

Free Cash Flow

865,000

Item

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Net Income from Continuing Operations

Depreciation and Amortization

Stock-based Compensation

Other Non-cash Items

Adjustments to Net Income

Other Operating Activity

Change in Working Capital

Change in Account Receivables

Change in Trade Receivables

Change in Inventory

Change in Payables and Accrued Expenses

Other Working Capital Changes

Cash Flow from Operating Activities

5.70M

4.13M

10.84M

8.23M

-27.78M

1.55M

-2.40M

-26.93M

1.12M

Net Fixed Asset Activity

Net Investment Securities Activity

Other Investing Activity

Cash Flow from Investing Activities

-252,000

-42,000

Net Borrowings

Net Issuance / Repurchase of Stock

Issuance of Capital Stock

Total Dividends Paid

Net Dividends Paid

Treasury / Other Financing Activity

Cash Flow from Financing Activities

13.90M

Beginning Cash and Cash Equivalents

Net Change in Cash and Cash Equivalents

Exchange Rate Changes

Ending Cash and Cash Equivalents

Free Cash Flow

39.46M

14.97M

54.43M

865,000

Unlock Long-Term Cash Flow Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan